Study of Hemay005 for moderate to severe COPD
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests a new medicine, Hemay005, in adults with moderate to severe COPD who also have a chronic cough with mucus. It looks at how the drug affects certain markers in the body related to the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have had COPD for at least 1 year and have a daily cough with mucus for at least 3 months in the last 2 years.
- You use maintenance inhalers (such as steroids or long-acting bronchodilators) regularly, and your dose has not changed in the last 28 days.
- You have not had a COPD flare-up needing steroids or antibiotics in the past 6 weeks.
- You do not have asthma, certain other lung diseases, or active infections like hepatitis B, C, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests an investigational drug called R-3750 in patients with mild to moderate COPD. It aims to see if the drug is safe and helps control symptoms. Eligible patients must have had COPD for at least a year, have mild to moderate airflow limitation, and have had at least one COPD flare-up in the past year.
This study tests whether a new inhaled medication called HSK39004 is safe and effective for people with moderate to severe COPD (a lung disease that makes breathing difficult). You would use this medicine regularly over a long period and have your lung function and symptoms checked.
This trial tests an experimental tablet called XH-S004 for people with moderate-to-severe COPD. It looks at how safe the drug is, how the body processes it, and if it helps symptoms.
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.